Alzheimer’s Drug Might Bring an End to Dental Fillings

0
872

Dentist

Tooth decay destroys dentine, the strong bony tissue that makes up¬†most of¬†the interior of¬†human teeth. Without the dentine, the pulp in¬†the tooth’s center that contains blood vessels and nerves becomes vulnerable. While stem cells within¬†the tooth are capable of¬†regenerating dentine, they cannot do so in¬†great enough amounts to¬†fill larger cavities.

When introduced to¬†a damaged tooth, Tideglusib, an anti-Alzheimer’s drug, causes the stem cells to¬†greatly increase their production of¬†dentine, eventually repairing the tooth. The King’s College team showed that a small collagen sponge could be soaked in¬†the drug and inserted into¬†a cavity.

Over a six-week period, the sponge would melt and release the drug into the cavity, repairing the dentine in a much simpler, cheaper, and safer manner than the usual drilling and filling.



Zimmer Biomet

US Dental Device Company to Pay $17Mln for Bribing Foreign Officials

Ordinarily, a major cavity is filled with a special cement or similar substance, but this is an inelegant solution as it replaces bone tissue with synthetic material. Additionally, cement is prone to infection and often needs to be replaced. In many cases, fillings beget more fillings, as the damage spreads.

Tideglusib sponges have no such risks, according to¬†Dr. Nigel Carter with¬†the Oral Health Foundation. “This is an extremely interesting and novel approach which shows great promise and we will look forward to¬†it being translated into¬†clinical application,” he told The Telegraph.

“Creating a more natural way for¬†the tooth to¬†repair itself could not only eliminate [issues with¬†fillings], but¬†also be a far less invasive treatment option for¬†patients. With dental phobia still being very common, using a natural way to¬†stimulate the renewal of¬†dentine could be an especially comforting proposal for¬†these groups.”

In short, fillings could soon be made obsolete.

A new promising medicine may treat Alzheimer's disease

Promising New Treatment for Alzheimer’s Disease May Be on the Horizon

Tideglusib’s dental properties have thus far only been demonstrated on¬†the teeth of¬†mice, but, as¬†the drug has been shown to¬†be safe in¬†previous trials with¬†Alzheimer’s patients, it may be fast-tracked into¬†commercial use, according to¬†study lead Paul Sharpe.

“Using a drug that has already been tested in¬†clinical trials for¬†Alzheimer’s disease provides a real opportunity to¬†get this dental treatment quickly into¬†clinics,” he said. He has announced a new trial to¬†test the drug on¬†larger rat teeth next.

Tideglusib has also entered stage II clinical trials to¬†act as¬†an inhibitor of¬†GSK-3, an enzyme that is believed to¬†be the source of¬†Alzheimer’s disease. GSK-3 has been shown to¬†prevent stem cells in¬†a tooth from¬†generating large amounts of¬†dentine.

Resources

ATTENTION READERS

We See The World From All Sides and Want YOU To Be Fully Informed
In fact, intentional disinformation is a disgraceful scourge in media today. So to assuage any possible errant incorrect information posted herein, we strongly encourage you to seek corroboration from other non-VT sources before forming an educated opinion.

About VT - Policies & Disclosures - Comment Policy
Due to the nature of uncensored content posted by VT's fully independent international writers, VT cannot guarantee absolute validity. All content is owned by the author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners, or technicians. Some content may be satirical in nature. All images are the full responsibility of the article author and NOT VT.